The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment
- PMID: 15804918
- DOI: 10.1080/13554790490903038
The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment
Abstract
Possession of one or more copies of the apolipoprotein E (APOE) epsilon4 allele is a known risk factor for Alzheimer's disease (AD), but it is uncertain whether the epsilon4 allele is associated with disease incidence among persons with mild cognitive impairment (MCI). We addressed this issue with data from the Religious Orders Study. Participants were 181 older Catholic clergy members who met criteria for MCI based on a uniform structured clinical evaluation; 56 (30.9%) had at least one epsilon4 allele. Clinical evaluations, which included clinical classification of dementia and AD, were repeated annually. During a mean of 5.7 years of observation, 79 persons (43.6%) developed AD. In a proportional hazards model that controlled for age, sex, and education, possession of an epsilon4 allele was associated with a 93% increase in the risk of developing Alzheimer's disease (95% CI; 1.02, 2.63). There was a marginally significant reduction in the effect of epsilon4 in older compared to younger participants (p=.053). The results suggest that possession of an epsilon4 allele does increase risk of AD in persons with MCI.
Similar articles
-
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.Arch Neurol. 2005 Jun;62(6):975-80. doi: 10.1001/archneur.62.6.975. Arch Neurol. 2005. PMID: 15956169
-
Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.CMAJ. 2004 Oct 12;171(8):863-7. doi: 10.1503/cmaj.1031789. CMAJ. 2004. PMID: 15477624 Free PMC article.
-
[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].Rev Neurol. 2004 May 1-15;38(9):801-7. Rev Neurol. 2004. PMID: 15152345 Spanish.
-
Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.Alzheimers Dement. 2011 Jul;7(4):e118-23. doi: 10.1016/j.jalz.2010.06.003. Epub 2011 Jun 14. Alzheimers Dement. 2011. PMID: 21665554 Review.
-
APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease.Alzheimers Dement. 2014 Nov;10(6):861-8. doi: 10.1016/j.jalz.2014.06.015. Epub 2014 Sep 10. Alzheimers Dement. 2014. PMID: 25217293 Review.
Cited by
-
Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations.Eur J Neurol. 2021 Jun;28(6):1859-1867. doi: 10.1111/ene.14841. Epub 2021 Apr 14. Eur J Neurol. 2021. PMID: 33780585 Free PMC article.
-
Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4. Neurobiol Aging. 2015. PMID: 25189118 Free PMC article.
-
Overview and findings from the religious orders study.Curr Alzheimer Res. 2012 Jul;9(6):628-45. doi: 10.2174/156720512801322573. Curr Alzheimer Res. 2012. PMID: 22471860 Free PMC article.
-
Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.J Alzheimers Dis. 2010;19(1):229-51. doi: 10.3233/JAD-2010-1255. J Alzheimers Dis. 2010. PMID: 20061642 Free PMC article. Review.
-
Comparing predictors of conversion and decline in mild cognitive impairment.Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30. Neurology. 2010. PMID: 20592257 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous